[1]
Dekalo, S. et al. 2022. 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for patients with favorable intermediate-risk prostate cancer. Canadian Urological Association Journal. 16, 7 (Feb. 2022), E381–5. DOI:https://doi.org/10.5489/cuaj.7739.